TCL Archive In Brief: Zubrod “One Person Who Made The Difference” In Drug Program, DeVita Says in Center’s 25th July 27, 1984
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive Administration to Request 3.9% Increase for NIH; 1.3% Raise For NCI In FY97 March 8, 1996
TCL Archive Two Breast Cancer Program Announcements Listed On Screening, Genetic Susceptibility February 1, 1980
